Servier takes NICE to court over Protelos guidance
This article was originally published in Scrip
Executive Summary
Servierhas asked an English court for a judicial review of theNational Institute for health and Clinical Excellence's guidance on the primary and secondary prevention of osteoporotic fractures in elderly women. The company is challenging the guidance because it believes that access to its Protelos (strontium ranelate) is being restricted unnecessarily and unfairly for many patients who could benefit from it.